Earnings

Noah Reports Q2 Earnings, Driven by Robust Growth in Overseas Markets

2024-08-29 14:51 17382

SHANGHAI, Aug. 29, 2024 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive advisory services on global investment and asset allocation primarily for Mandarin-speaking high-net...

Noah Reports Q2 Earnings, Driven by Robust Growth in Overseas Markets

2024-08-29 14:47 2673

SHANGHAI, Aug. 29, 2024 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive advisory services on global investment and asset allocation primarily for Mandarin-speaking high-net...

Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results

2024-08-29 14:31 2657

2024 Interim Result Highlights (For the six months ended June 30, 2024) * Company published the efficacy and safety data of Cohort-G of TranStar102 study for osemitamab (TST001), plus checkpoint inhibitor and CAPOX as the first-line treatment of patients with locally advanced or metastatic G/GE...

111, Inc. Announces Second Quarter 2024 Unaudited Financial Results

2024-08-29 14:00 2766

* Maintained Operational Profitability for the Second Consecutive Quarter * Operating Expenses as a Percentage of Revenues Decreased 120 Basis Points YoY * Held Positive Operating Cash Flow for Two Consecutive Quarters SHANGHAI, Aug. 29, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company"...

NOAH HOLDINGS LIMITED ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE SECOND QUARTER OF 2024

2024-08-29 04:45 4175

SHANGHAI, Aug. 28, 2024 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive one-stop advisory services on global investment and asset allocation primarily for Mandarin-speaking...

Akeso's 2024 First Half Interim Results: Expanding Global Lead in IO Bispecific Antibodies, Advancing New Therapies, and Accelerating Commercialization

2024-08-29 04:20 2327

* Approval of ivonescimab for 2L+ EGFRm NSCL; HARMONi-A is the only phase III study that demonstrates significant benefit across all subgroups for PFS, and is also the only study to achieve the primary endpoint while showing a positive trend in OS benefit; HARMONi-A study presented in an oral p...

Fosun Int'l: Total Revenue for 1H2024 Reaches RMB97.84 Bn, Industrial Operation Profit Amounts to RMB 3.47 Bn

2024-08-28 21:51 2769

Powered by Core Strengths, Focus on Core Businesses & Reinforce Organic Growth Momentum 2024 Interim Results Highlights: * Total revenue maintained growth, reaching RMB97.84 billion; * Industrial operation profit maintained growth, reaching RMB3.47 billion; * Continued focus on core busines...

Asieris Pharmaceuticals Releases 2024 Semi-Annual Report, Highlighting Steady Progress in Launching Blockbuster Product for Precancerous Cervical Lesions and Continued Strengthening of Commercial Revenue Generation Capabilities

2024-08-28 21:34 2062

As of the date of this publication, APL-1702 has not been approved for the treatment of cervical high-grade squamous intraepithelial lesions (HSIL); APL-1706 has not been approved for the diagnosis or surgical treatment of bladder cancer inChina. This article is intended to disclose the latest d...

Fosun Intl 1H Revenue Keeps Growing, Debt Ratio Reduces to 50.2%

2024-08-28 21:34 2517

HONG KONG, Aug. 28, 2024 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656) announced its interim results for the six months ended30 June 2024. During the Reporting Period, the Group's revenue continued to grow, reachingRMB97.84 billion; industrial operation profit maintained gr...

Jenscare, with innovative TTVR, releases 2024H1 interim results

2024-08-28 21:00 2224

BEIJING, Aug. 28, 2024 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases with TTVR breakthroughs, released interim results for 2024H1 endedJune 30, 2024...

Innovent Announces 2024 Interim Results and Business Updates

2024-08-28 18:42 2889

Strong commercial performance and significant pipeline milestones support sustained growth and innovation SAN FRANSISCO and SUZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and com...

Baozun Announces Second Quarter 2024 Unaudited Financial Results

2024-08-28 18:35 2337

SHANGHAI, Aug. 28, 2024 /PRNewswire/ -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a leading brand e-commerce solution provider and digital commerce enabler inChina, today announced its unaudited financial results for the second quarter endedJune 30, 2024....

Tigermed Reports 2024 Interim Results

2024-08-28 18:26 1862

HANGZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecycle of global biopharmaceutical and medical device products, announced its int...

Record High Interim Dividend Declared as Net Profit Soars----CNOOC Limited Announced Its 2024 Interim Results

2024-08-28 18:17 1984

HONG KONG, Aug. 28, 2024 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announced today its 2024 interim results. * Making solid progress in reserves and production growth, net production increases by 9.3% year-on-year ("YoY") ...

Fosun Pharma Announces 2024 Interim Results

2024-08-28 18:10 1874

Breakthroughs for Innovative Products Going Overseas with Global Operation Capabilities Continuing to Strengthen SHANGHAI, Aug. 28, 2024 /PRNewswire/ -- On August 27, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; Stock Code: 600196.SH; 02196.HK), announced its o...

Quhuo Reports Unaudited Financial Results for the First Half of 2024

2024-08-28 18:00 1734

BEIJING, Aug. 28, 2024 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo," the "Company," "we" or "our"), a leading gig economy platform focusing on local life services inChina, today reported its unaudited financial results for the six months endedJune 30, 2024. Financial and Operational Highl...

Quhuo Announces Unaudited Financial Results for the First Half of 2024: Precise Strategy Spurs Strong Growth in Mobility Service and Homestay

2024-08-28 18:00 1817

* Revenues from mobility service solutions were RMB100.5 million (US$13.8 million), representing an increase of 71.7% year-over-year. * Quhuo International shipped 815 vehicles under its vehicle export solutions. * The Company has expanded services to 132 cities nationwide, representing a 21....

Kerry Logistics Network Posts 126% Growth in Profit Attributable to the Shareholders, Outperforms the Market in terms of Growth in Core Net Profit

2024-08-28 17:43 1961

HONG KONG, Aug. 28, 2024 /PRNewswire/ -- Kerry Logistics Network Limited ('Kerry Logistics Network' or together with its subsidiaries, the 'Group' or 'KLN Group'; Stock Code 0636.HK) today announced the Group's interim results for the six months ended30 June 2024. Group's Financial Highlights ...

Harbour BioMed Announces 2024 Interim Results

2024-08-28 17:44 1834

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Harbour BioMed ("HBM", or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology an...

DPC Dash Ltd Announces 2024 Interim Financial Results

2024-08-28 17:20 3554

Revenues increased to RMB2.04 billion, representing 48.3% year-over-year growth Adjusted net profit reached RMB50.9 million, from an adjusted net loss of RMB17.4 million in the same period of 2023 Store-level operating profit grew by 59.0%; Adjusted group EBITDA increased by 83.7% Added 146 net...

1 ... 6789101112 ... 289